34-3 Surgical Pearls from the Weil Foot and Ankle Institute

Current Status
Not Enrolled
Price
$89.00
Get Started

EDITORIAL

» It is with great pleasure that I serve as Guest Editor for this issue of Foot and Ankle Quarterly, devoted to Surgical Pearls from the Weil Foot and Ankle Institute. ...

Most if not all of the procedures developed, refined and taught by Drs. Lowell Scott Weil, Sr. and Lowell Weil, Jr., as well as their myriad students, residents, and fellows have stood the test of time. The procedures born within the Weil Foot and Ankle Institute (WFAI) have been universally adopted by national and international foot and ankle surgeons of every physician and surgeon degree.

One of the most endearing qualities of Drs. Weil, Sr. and Weil, Jr. is that they have never been afraid to recommend against certain procedures if they believed wide adoption would harm patients. This is exceedingly rare in any surgical specialty. Therefore, the intent of this seminar issue is to provide review of pertinent literature specific to WFAI procedures including the good, bad and ugly. Accordingly, the feature article covers the use of advanced tips and tricks pertinent to complex forefoot surgery. A series of seminal manuscripts published by members of WFAI follows, and we conclude with audio lectures detailing “in-the-trenches” pearls on managing hallux varus, as well as the mastery of the Weil central metatarsal osteotomy.

My hope is that the readers of this issue of FAQ will enjoy this seminar, and benefit from the surgical experience of the authors and manuscripts selected as much as I have.

Thomas S. Roukis, DPM, PhD, FACFAS


2023 by Data Trace Publishing Company. All rights reserved. Reproduction or translation of any part of this work beyond that permitted by Section 107 or 108 of the United States Copyright Law without the permission of the copyright owner is unlawful. No portion(s) of the work(s) may be reproduced without written consent from Data Trace Publishing Company. Permission to reproduce copies of articles for non-commercial use may be obtained for a fee of $22 per copy from the Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400, www.copy right.com.

The ideas and opinions expressed in Foot and Ankle Quarterly are those of the authors and do not necessarily reflect those of the Editor or the Publisher. Publication of an advertisement or other product mentioned in Foot and Ankle Quarterly should not be construed as an endorsement of the product of the manufacturer’s claims. Readers are encouraged to contact the manufacturer with any questions about the features or limitations of the products mentioned. The Publisher does not assume any responsibility for any injury and/or damage to any persons or property arising out of or related to any use of the material contained in this periodical. The reader is advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each device or of each drug to be administered to verify the dosage, the method and duration of administration, or contraindications. It is the responsibility of the treating physician or other healthcare professionals, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient.

Disclosure

Data Trace Publishing Company Continuing Education Mission Statement

Data Trace Publishing Company is committed to providing high-quality print and internet-based enduring continuing education programs, including lectures, feature articles, and condensations and commentaries on current clinical podiatric topics and medical risk management topics which lead to improved delivery of patient care and help reduce the potential for medical errors. These programs are provided to meet the educational needs of the podiatric medical profession and thereby enhance the quality of patient care.

Program Objectives

Foot and Ankle Quarterly (FAQ) is a unique program designed to help today’s podiatric physician manage an ever-increasing flow of information. After completing the Foot and Ankle Quarterly, Volume 34 program, the learner should be better able to: develop and refine a perspective on current treatment recommendations, updates, and advances pertinent to podiatric practice; evaluate the implications of the learned information as it pertains to the diagnosis and treatment of podiatric disorders and societal issues and barriers, and; apply current trends, standards, and best practices into learner’s own practice.

Data Trace Publishing Company Continuing Education Accreditation Statement

Data Trace Publishing Company is approved by the Council on Podiatric Medical Education (CPME) as a provider of continuing education in podiatric medicine. Data Trace Publishing Company has approved this activity for a maximum of 6 continuing education contact hours (CECHs). Physicians should claim only the contact hours commensurate with the extent of their participation in the activity.

Estimated time to complete activity: 6 hours
Date of release: December 15, 2023
Expiration Date: December 15, 2026 (unless further validated and extended by provider). For amended dates of activity expiration, please see FAQ Activity Effective Dates at www.datatrace.com).

Commercial Interests

No commercial interest provided financial support for this continuing education activity.

CECH Note
Participants of Volume 34, Issue 3 will receive a maximum of 6 CECHs for a correctly-completed CME Answer Form. In order to qualify for CECHs, a score of 70% or more must be achieved on the written examination material. Any participant who does not pass the first time may take the exam one additional time (within 90 days of receipt of results). One retake test may be taken for a fee of $15. You will be responsible for notifying your state of the number of contact hours you have received.

Participants are required to complete a course evaluation for use in developing future issues and to meet the unique educational needs of podiatric physicians.

FINANCIAL DISCLOSURE INFORMATION

It is the policy of Data Trace Publishing Company to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. All faculty, presenters, speakers, authors, and reviewers participating in any programs provided by Data Trace Publishing Company are expected to disclose any relevant financial relationships with CPME-defined commercial interests to the program audience. “Relevant financial relationships” are financial relationships of the individual (including those of the individual’s spouse or partner) in any amount occurring within the past 12 months that create a conflict of interest. A commercial interest is any organization manufacturing, producing, marketing, re-selling, or distributing healthcare goods or services consumed by or used on patients. The CPME mandates that the content of accredited activities be objective and independent of commercial bias. The intent of this policy is that readers may form their own judgements about the presentations, using independent review to resolve all identified conflicts of interest.

In addition to disclosing commercial relationships, faculty are advised of the following policies:

Each continuing education planner and author has submitted a Conflict of Interest Disclosure in order to identify relevant financial relationships and resolve conflicts.

Limitations on Data: Presenter will ensure, to the extent possible, meaningful disclosure of limitations on data (e.g., ongoing research, interim analyses, preliminary data, or unsupported opinion).

Discussion of Unapproved Uses: If unapproved (unlabeled) uses are discussed during the continuing education activity, the presenter will disclose when a product is not approved in the United States (and/or the nation where the activity takes place) for the use under discussion.

Data Trace Publishing Company has identified the option to disclose as follows:

The following authors have disclosed whether they or a member of their immediate family:

  1. Will be receiving an honorarium for this activity
  2. Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they will refer as speaker or author:
    1. Received monetary or other significant research support
    2. Are or had been a paid consultant
    3. Are or had been a full-time or part-time employee
    4. Are or had been a paid or unpaid member of an advisory or similar board
    5. Are or had been a member or on the Board of Trustees
    6. Other
  3. Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they will refer as speaker or author, BUT will not be recommending any of their products over similar competitor products
  4. Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they will refer as speaker or author, AND will be recommending one or more of their products over similar competitor products. Recommendation will be based on:
    1. Exclusively on data and/or clinical experience not generated by the manufacturer or derived from manufacturer-sponsored studies
    2. Data and/or clinical experience most of which were not generated by the manufacturer or derived from manufacturer-sponsored studies
    3. Data and/or clinical experience, most of which were generated by the manufacturer or derived from manufacturer-sponsored studies
    4. Exclusively on data and/or clinical experience generated by the manufacturer or derived from manufacturer or derived from manufacturer-sponsored studies
    5. Have no conflicts to disclose

Article Authors and Lecturers

  • John S. Anderson, DPM, FACFAS (1. Data Trace Publishing Co.)
  • Jeffrey Baker, DPM (n.)
  • Jarret D. Cain, DPM, MSc (1. Data Trace Publishing Co.)
  • Kristina Corley, DPM (n.)
  • Firas Katmeh, DPM, MSH (n.)
  • Mark K. Magnus, DPM, FACFAS (n.)
  • Michael Radcliffe, DPM (n.)
  • Thomas S. Roukis, DPM, PhD, FACFAS (1. Data Trace Publishing Co.)
  • Jennifer So, DPM (n.)
  • Alexsandra Szajna, DPM (n.)
  • Lowell Weil, Jr., DPM, FACFAS (1. Data Trace Publishing Co.)
  • Isaac Wilmot, DPM (n.)
  • Lindsay Wynn, DPM (n.)

 FAQ Journal Planning Committee

  • Chrissy Wesolowski (n.)
  • Lauren Molander (n.)
  • Stephanie Wu, DPM, MSc (n.)

The content and opinions in this issue are strictly those of the authors, and do not represent the views of the United States Department of Veterans Affairs or the United States Government.

Foot and Ankle Quarterly 34-3 Contributors

Guest Editor

Thomas S. Roukis, DPM, PhD, FACFAS
Past President (2014-2015), American College of Foot and Ankle Surgeons; Editor-in-Chief, Foot and Ankle Surgery: Techniques, Reports and Cases (FASTRAC); Clinical Professor, Department of Orthopaedic Surgery and Rehabilitation, Division of Foot and Ankle Surgery, University of Florida College of Medicine, Jacksonville, FL

Contributors

John S. Anderson, DPM, FACFAS
Assistant Professor, Division of Foot and Ankle Surgery, Department of Orthopaedic Surgery and Rehabilitation, University of Florida College of Medicine, Jacksonville, FL

Jeffrey Baker, DPM
Weil Foot and Ankle Institute, Chicago, IL

Jarret D. Cain, DPM, MSc
Associate Professor, University of Pittsburgh Physicians, University of Pittsburgh School of Medicine, Pittsburgh, PA

Kristina Corley, DPM
Fellow (2023 – 2024), Weil Foot & Ankle Institute, Lake Forest, IL

Firas Katmeh, DPM, MSH
Podiatric Medicine and Surgery PGY-2 Resident, Division of Foot and Ankle Surgery, Department of Orthopaedic Surgery and Rehabilitation, University of Florida College of Medicine, Jacksonville, FL

Mark K. Magnus, DPM, FACFAS

Michael Radcliffe, DPM
Podiatric Medicine and Surgery PGY-3 Resident, Division of Foot and Ankle Surgery, Department of Orthopaedic Surgery and Rehabilitation, University of Florida College of Medicine, Jacksonville, FL

Jennifer So, DPM
Podiatric Medicine and Surgery PGY-3 Resident, Division of Foot and Ankle Surgery, Department of Orthopaedic Surgery and Rehabilitation, University of Florida College of Medicine, Jacksonville, FL

Alexsandra Szajna, DPM
Podiatric Medicine and Surgery PGY-2 Resident, Division of Foot and Ankle Surgery, Department of Orthopaedic Surgery and Rehabilitation, University of Florida College of Medicine, Jacksonville, FL

Lowell Weil, Jr., DPM, FACFAS
Executive Chairman, Balance Health; Founder, Foot and Ankle Business Innovations (FABI); Editor Emeritus, Foot and Ankle Specialist; Physician and former Fellowship Director (1998 – 2018), Weil Foot & Ankle Institute, Lake Forest, IL

Isaac Wilmot, DPM
Podiatric Medicine and Surgery PGY-2 Resident, Division of Foot and Ankle Surgery, Department of Orthopaedic Surgery and Rehabilitation, University of Florida College of Medicine, Jacksonville, FL

Lindsay Wynn, DPM
Podiatric Medicine and Surgery PGY-3 Resident, Division of Foot and Ankle Surgery, Department of Orthopaedic Surgery and Rehabilitation, University of Florida College of Medicine, Jacksonville, FL


34-3 In this issue:

  • FEATURE ARTICLE: Weil Osteotomy and Plantar Plate Repair: Honoring Dr. Lowell Scott Weil, Sr.’s Greatest Surgical Legacy – His Innovation
    Lowell Weil, Jr., DPM, FACFAS and Kristina Corley, DPM
  • CONDENSATIONS and COMMENTARIES
    • Total First Metatarsophalangeal Joint Implant Arthroplasty: A 30-Year Retrospective
      Commentary by Mark K. Magnus, DPM, FACFAS
    • Percutaneous Chevron/Akin vs. Open Scarf/Akin Osteotomy Treatment for Hallux Valgus: A Systematic Review and Meta-Analysis
      Commentary by Jeffrey Baker, DPM
    • Unilateral vs. Bilateral First Ray Surgery: A Prospective Study of 186 Consecutive Cases. Patient Satisfaction, Cost to Society and Complications
      Commentary by Jennifer So, DPM
    • Predicting Articular Erosion in Hallux Valgus: Clinical, Radiographic and Intra-Operative Analysis
      Commentary by Michael Radcliffe, DPM
    • Do Patient Personality Traits and Self-Reported Physical and Psychosocial Symptoms Help to Predict Hallux Valgus Surgery Outcomes?
      Commentary by Firas Katmeh, DPM, MSH
    • Joint Manipulation under Anesthesia for Arthrofibrosis after Hallux Valgus Surgery
      Commentary by Isaac Wilmot, DPM
    • Association between Second Metatarsal Length and Forefoot Loading under the Second Metatarsophalangeal Joint
      Commentary by Firas Katmeh, DPM, MSH
    • Scarfette Osteotomy for Surgical Treatment of Bunionette Deformity
      Commentary by Lindsay Wynn, DPM
    • Retrospective Comparative Study of Operative Repair of Hammertoe Deformity
      Commentary by Firas Katmeh, DPM, MSH
    • Forefoot Adduction is a Risk Factor for Jones Fracture
      Commentary by Alexsandra Szajna, DPM
  • AUDIO LECTURE 1: Hallux Varus: The X, Y and Z
    John S. Anderson, DPM, FACFAS
  • AUDIO LECTURE 2: Weil Metatarsal Osteotomy: History, Concepts and Evolution?
    Jarret D. Cain, DPM, MSc
  • CONTINUING EDUCATION QUESTIONNAIRE